Hormone therapy in women in the menopause transition: Randomised, double‐blind, placebo‐controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin Ill activity, and the endometrium

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Medical Journal of Australia

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5694/j.1326-5377.1998.tb140133.xPMID 9539899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid hormones and distribution of adipose tissue.

  2009cited by this paper
• Risk Factors Associated with Women's Compliance with Estrogen Replacement Therapy

  1997cited by this paper
• Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.

  1996cited by this paper
• Hormone replacement therapy and breast cancer: an overview.

  1996cited by this paper
• Are changes in lipoproteins during HRT important?

  1996cited by this paper
• Prospective study of exogenous hormones and risk of pulmonary embolism in women.

  1996cited by this paper
• Risk of venous thromboembolism in users of hormone replacement therapy.

  1996cited by this paper
• Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

  1995cited by this paper
• Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study.

  1995cited by this paper
• Effect of Continuous Combined Estrogen and Desogestrel Hormone Replacement Therapy on Serum Lipids and Lipoproteins

  1994cited by this paper
• Hormone replacement therapy and breast cancer

  1994cited by this paper
• Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women.

  1994cited by this paper
• Changes in the low-density lipoprotein profile during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women.

  1994cited by this paper
• Long-Term Effects of Oral and Transdermal Hormone Replacement Therapies on Serum Lipid and Lipoprotein Concentrations

  1994cited by this paper
• Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.

  1993cited by this paper
• Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.

  1992cited by this paper
• Weight gain at the time of menopause.

  1991cited by this paper
• Prevalence of obesity in Sweden: cross‐sectional study of a representative adult population

  1990cited by this paper
• Oestrogen-progestogen replacement therapy changes body composition in early post-menopausal women.

  1986cited by this paper
• Coagulation and Fibrinolysis in Estrogen-Treated Surgically Menopausal Women

  1984cited by this paper
• Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems.

  1979cited by this paper
• Conjugated equine oestrogens and blood clotting: a follow-up report.

  1977cited by this paper
• BODY COMPOSITION STUDIES OF “OLDER” WOMEN, THIRTY TO SEVENTY YEARS OF AGE *

  1963cited by this paper

• Is Waist-Circumference Related to Anxiety Levels in Peri and Postmenopausal Women?

  2024cites this paper
• Patterns of care of cervical cancer in the elderly: A qualitative literature review.

  2017cites this paper
• The Coexistence of Hypertension and Ovariectomy Additively Increases Cardiac Apoptosis

  2016cites this paper
• Emulation of Target Trials to Study the Effectiveness and Safety of Medical Interventions

  2015cites this paper
• Individual differences in the propensity of female rhesus monkeys (Macaca mulatta) to gain and lose body weight

  2006cites this paper
• Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.

  2004cites this paper
• Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women

  2004cites this paper
• One year follow-up of hormone replacement therapy with percutaneous estradiol and low-dose vaginal natural progesterone in women with mild to moderate hypertension.

  2003cites this paper
• Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal women

  2003cites this paper
• Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome.

  2002cites this paper
• Veränderungen des Gewichts in den verschiedenen Phasen des Klimakteriums und unter dem Einfluß der Hormonersatztherapie

  2002cites this paper
• Body mass index in mid-life women: relative influence of menopause, hormone use, and ethnicity

  2001cites this paper
• Oral oestrogen replacement therapy versus placebo for hot flushes.

  2001cites this paper
• Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

  2001cites this paper
• Estrogen-Progestin Hormone Replacement Therapy: Evaluation of Epidemiological Studies

  2001cites this paper
• The roles of gender, the menopause and hormone replacement on cardiovascular function.

  2000cites this paper
• Weight gain and the menopause: a 5-year prospective study.

  1999cites this paper
• Respiratory insufficiency in postmenopausal women: sustained improvement of gas exchange with short-term medroxyprogesterone acetate.

  1999cites this paper
• Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.

  1999cites this paper
• Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.

  1999cites this paper